Abstract
An increasing number of patients with chronic kidney disease (CKD) including those with end-stage renal disease (ESRD) on renal replacement therapy present each year for dental care. This increase is due, in part, to the rising prevalence of type 2 diabetes and the aging population demographics of industrialized nations. However, advances in renal replacement technologies have also greatly increased the life expectancies for ESRD patients thereby increasing the size of this patient population. In addition, not only will the dental profession be asked to care for an increasing number of CKD patients, but recent studies suggest that periodontitis may affect the medical management of the CKD patient. Adverse outcomes including mortality have been associated with increased systemic inflammation in both the CKD and the general population making means to decease systemic inflammation an emerging medical concern [1, 2]. For patients receiving hemodialysis maintenance therapy, for example, increased systemic inflammation has been closely associated with atherosclerotic complications including myocardial infarction and stroke, which are among the most frequent causes of mortality in this patient population [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Meuwese CL, Stenvinkel P, Dekker F, Carrero JJ. Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol. 2011;7:166–76.
Miyamoto T, Carrero JJ, Stenvinkel P. Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20:662–8.
Yeun JY, Levine RA, Mantadilok V, et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis populations. Am J Kidney Dis. 2000;35:469–76.
Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, Ridker PM, Van Dyke TE, Roberts WC. The American Journal of Cardiology and Journal of Periodontology editor’s consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol. 2009;104:59–68.
Lockhart PB, Bolger AK, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornick HL, Gewitz MH, Wilson WR, Smith SC, Baddour LM. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A statement from the American Heart Association. Circulation. 2012;125:2520–44.
Akar H, Aka GC, Carrero JJ, Stenvinkel P, Lindholm B. Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol. 2011;6:218–26.
Craig RG, Kotanko P, Kamer AR, Levin NW. Periodontal diseases – a modifiable source of systemic inflammation for the end-stage renal disease patient on haemodialysis therapy? Nephrol Dial Transplant. 2007;22:312–5.
Fogo A, Kon W. Pathophysiology of progressive chronic renal disease. In: Avner EE, Harmon WE, Niaudet P, et al., editors. Textbook of pediatric nephrology. 5th ed. Philadelphia: Lippincott/Williams & Wilkins; 2004. p. 1267–480.
Vanholder R, De Smet R, Glorieux G, et al. European Uremic Toxin Work Group (EUTox). Review on uremic toxins: classification, concentration, and inter individual variability. Kidney Int. 2003;63(5):1934–43.
Saran R, Li Y, Robinson B, et al. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2015;66(1 suppl 1):S1–306.
Seikaly M, Ho PL, Emmett L, et al. The 12th annual report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998. Pediatr Transplant. 2001;5(3):215–31.
Noh H, Lee SW, Kang SW, Shin SK, Choi KH, Lee HY, Han DS. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant. 1998;18:387–94.
Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14:1956–60.
Zimmerman J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–58.
Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351(25):2599–610.
Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557–65.
Chuang SF, Sung JM, Kuo SC, Huang JJ, Lee SY. Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:689–95.
Chen LP, Chiang CK, Chan CP, Hung KY, Huang CS. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis. 2006;47:815–22.
Borawski J, Wilczynska-Borawska M, Stokowska W, Mysliwiec M. The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients. Nephrol Dial Transplant. 2007;22:457–64.
Bastos JA, Diniz CG, Bastos MG, Vilela EM, Silva VL, Chaubah A, Souza-Costa DC, Andrade LCF. Identification of periodontal pathogens and severity of periodontitis in patients with and without chronic kidney disease. Arch Oral Biol. 2011;56:804–11.
Thorman R, Neovius M, Hylander B. Clinical findings in oral health during progression of chronic kidney disease to end-stage renal disease in a Swedish population. Scand J Urol Nephrol. 2009;43:154–9.
Messer MD, Emde K, Stern L, Radhakrishanan J, Vernocchi L, Cheng B, Angelopoulos C, Papapanou PN. Radiographic periodontal bone loss in chronic kidney disease. J Periodontol. 2012;83:602–11.
Zhao D, Zang S, Chen X, Liu W, Sun N, Guo Y, Dong Y, Mo A, Yuan Q. Evaluation of periodontitis and bone loss in patients undergoing hemodialysis. J Periodontol. 2014;85:1515–20.
Davidovich E, Schwarz Z, Davidovitch M, et al. Oral findings and periodontal status in children, adolescents and young adults suffering from renal failure. J Clin Periodontol. 2005;32(10):1076–82.
Proctor R, Kumar N, Stein A, et al. Oral and dental aspects of chronic renal failure. J Dent Res. 2005;84(3):199–208.
Souza CR, Libério SA, Guerra RN, et al. Assessment of periodontal condition of kidney patients in hemodialysis. Rev Assoc Med Bras. 2005;51(5):285–9.
Klassen JT, Krasko BM. The dental health status of dialysis patients. J Can Dent Assoc. 2002;68(1):34–8.
Castillo A, Mesa F, Liébana J, et al. Periodontal and oral microbiological status of an adult population undergoing haemodialysis: a cross-sectional study. Oral Dis. 2007;13(2):198–205.
Naugle K, Darby ML, Bauman DB, et al. The oral health status of individuals on renal dialysis. Ann Periodontol. 1998;3(1):197–205.
Craig RG. Interactions between chronic renal disease and periodontal disease. Oral Dis. 2008;14:1–7.
Raimann JG, Levin NW, Craig RG, Sirover W, Kotanko P, Handelman G. Vitamin C (L-ascorbic acid) in hemodialysis patients. Semin Dial. 2013;26:1–5.
Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsu S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3:1526–33.
Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 2006;70:358–62.
Kuroki Y, Tsuchida K, Go I, Aoyama M, Naganuma T, Takemoto Y, Nakatani T. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor 2 and 4 expression in peripheral blood monocytes of hemodialysis patients. Int J Mol Med. 2007;19:783–90.
Girndt M, Sester M, Sester U, Kaul H, Kohler H. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int. 2011;59:1382–9.
Sester U, Sester M, Hauk M, Kaul H, Kohler H, Girndt M. T-cell activation follows TH1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant. 2000;15:1217–23.
Shultis WA, Weil EJ, Looker HC, Curtis JM, Shlossman M, Genco RJ, Knowler WC, Nelson RG. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care. 2007;30:306–11.
Fisher MA, Taylor GW, Papapanou PN, Rahman M, Debanne SM. Clinical and serologic markers of periodontal infection and chronic kidney disease. J Periodontol. 2007;79:1670–8.
Fisher MA, Taylor GW, Shelton BJ, Jamerson KA, Rahman M, Ojo AO, Sehgal AR. Periodontal disease and other nontraditional risk factors for CKD. Am J Kidney Dis. 2007;51:45–52.
Fisher MA, Taylor GW, West BT, McCarthy ET. Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling. Kidney Int. 2011;79:347–55.
Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ. Periodontal disease is associated with renal insufficiency in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2005;45:650–7.
Lee CF, Lin CL, Lin MC, Lin SY, Sung FC, Kao CH. Surgical treatment for patients with periodontal disease reduces risk of end-stage renal disease: a nationwide population-based retrospective cohort study. J Periodontol. 2014;85:50–6.
Chen LP, Chiang CK, Peng YS, Hsu SP, Lin CY, Lai CF, Hung KY. Relationship between periodontal disease and mortality in patients treated with maintenance hemodialysis. Am J Kidney Dis. 2011;57:276–82.
Kshirsagar AV, Craig RG, Moss KL, Beck JD, Offenbacher S, Kotanko P, Klemmer PJ, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici EM, Usvyat LA, Falk RJ. Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int. 2009;75:746–50.
Siribamrungwong M, Puangpanngam K. Treatment of periodontal diseases reduces chronic systemic inflammation in maintenance hemodialysis patients. Ren Fail. 2012;34:171–5.
De Souza CM, Braosi APA, Luczyszyn SM, Olandoski M, Kotanko P, Craig RG, Trevilatto PC, Pecoits-Filho R. Association among oral health parameters, periodontitis and its treatment and mortality in patients undergoing hemodialysis. J Periodontol. 2014;85:e169–78.
Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natle P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, Del Castillo D, Bernat AG, Hegbrant J, Wolheim C, Gargano L, Bots CP, Strippoli GF. Dental health and mortality in people with end-stage kidney disease treated with hemodialysis: a multinational cohort study. Am J Kidney Dis. 2015;66:666–76.
Craig RG, Hunter JM. Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaesth. 2008;101(3):296–310.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Craig, R.G., Kotanko, P. (2016). Interactions Between Periodontal Disease and Chronic Kidney Diseases. In: Craig, R., Kamer, A. (eds) A Clinician's Guide to Systemic Effects of Periodontal Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49699-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-49699-2_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49697-8
Online ISBN: 978-3-662-49699-2
eBook Packages: MedicineMedicine (R0)